Stock screenerAll disclosures →
EDGAR →
BLLN
Conviction 14HealthcareScan · Mon, Aug 10, 2026BLLN$98.65+5.63%
ResistanceSupportVol 14Insider sell21
11
9
Vol MA14 908.9K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price98.65
Change+5.63%
Gap-0.23%
Rel volume0.73×
Avg volume822.83K
Avg $ vol97.89M
SMA 20127.04
SMA 50115.95
SMA 200—
Price vs 50-14.92%
Price vs 200—
MA stack—
50/200 cross—
Supertrenddown · 128.38
RSI (14)37
MACD hist-5.32
MACD crossbear · 2d
Stoch %K / %D16 / 9
ADX (14)36
+DI / −DI18 / 35
RSI divergence—
MACD divergence—
ATR %+10.82%
ADR %6.42%
52w high149.97
52w low64.03
From 52w high-34.22%
Above 52w low+54.07%
New 52w highNo
SqueezeOff
Bollinger width47.16%
%B0.03
Donchian pos15.97%
Donchian high150.44
Donchian low88.81
AVWAP (52w high)102.02
vs AVWAP high-3.30%
AVWAP (52w low)100.53
vs AVWAP low-1.87%
OBV trendFlat
Chaikin MF (20)0.14
Today vs 20d0.73×
Avg vol (14d)908.9K
Avg vol (20d)822.83K
Avg $ vol (20d)97.89M
Market cap1.1B
RS 3m (vs SPY)-5.17%
RS 6m (vs SPY)-4.44%
RS line new highNo
Trend template—
Technical rank29.9
1 week-28.16%
1 month-22.18%
3 months+6.12%
6 months+8.87%
1 year—
YTD+10.48%
P/E147.94
P/B2.05
P/S3.61
P/FCF70.18
EPS0.1400
Div yield—
ROE1.39%
ROA1.02%
Debt/Eq0.11
Current11.69
EV/EBITDA26.67
Gross margin68.32%
Net margin2.44%
Rev growth99.97%
EPS growth117.93%
Price target123.33
Target upside25.02%
Analyst ratingBuy
Institutional26.71%
Ent. value611.35M
Revenue109.45M
Net income8.05M
Gross profit77.11M
Free cash flow15.71M
IndustryDiagnostics & Research
ExchangeNasdaq
Shares out41.44M
Employees713
ListedThu, Nov 6, 2025
Free float16.28M
Float %39.5%
Short interest2.41M
Days to cover3.6d
Short volume53.6%
Squeeze score57 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.15 vs $0.15
Last surprise0.0% beat
Setup gradeD
Conviction14 / 100
Pattern quality—
Tech rank29.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance142.05
Support105.20
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BLLN
No recent disclosed trades by Congress in BLLN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BLLN · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-05 | Exercise | 15.54K | $44K | 2026-08-05 | 2026-08-07 |
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-05 | Sell | 15.54K | $2.3M | 2026-08-05 | 2026-08-07 |
Atay Oguzhan Chairman and CEO · Stock Option (right to buy) · 2026-08-05 | Exercise | 15.54K | $44K | 2026-08-05 | 2026-08-07 |
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-03 | Exercise | 20K | $56K | 2026-08-03 | 2026-08-05 |
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-03 | Exercise | 6.25K | $18K | 2026-08-03 | 2026-08-05 |
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-03 | Sell | 269 | $36K | 2026-08-03 | 2026-08-05 |
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-03 | Sell | 555 | $74K | 2026-08-03 | 2026-08-05 |
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-03 | Sell | 135 | $18K | 2026-08-03 | 2026-08-05 |
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-03 | Sell | 6.35K | $867K | 2026-08-03 | 2026-08-05 |
Atay Oguzhan Chairman and CEO · Class A Common Stock · 2026-08-03 | Sell | 9.99K | $1.4M | 2026-08-03 | 2026-08-05 |
SEC filings
EDGAR filings in BLLN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.